期刊文献+

抑癌基因maspin在肝癌组织中的表达及其临床意义 被引量:5

Expression of Tumor Suppressor Gene Maspin in Hepatocellular Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的探讨抑癌基因maspin在肝癌组织中的表达及其临床意义。方法选取肝癌组织及其癌旁肝组织各32例,另选择正常肝脏组织30例作为对照,采用免疫组化法检测3种组织中maspin基因的表达情况,并分析maspin基因表达与肝癌临床参数的关系。结果肝癌组织maspin基因阳性率(28.1%)显著低于癌旁组织(62.5%)和正常肝组织(86.7%);肝癌组织中maspin基因表达阳性率与肿瘤分化程度、有无肝内外转移有关(P<0.05),与年龄、性别、肿瘤直径、TMN分期和有无门静脉侵犯无关(P>0.05)。结论 maspin基因在肝癌组织中呈低表达,其表达情况可作为判断肝癌进展情况和恶性程度的指标之一。 Objective To explore the expression of turmor suppressor gene maspin in hepatocellular carcinoma and its clinical significance. Methods Thirty two patients with hepatocellular carcinoma were enrolled in the study,and 30 health cases as controls. Immunohistochemistry was used to detect the expressions of maspin in the targeted hepatocellular carcinoma tissue ,adjacent surrounding liver tissue and normal liver tissue,and relationship between maspin expression and clinical pathological parameters of hepatocellular carcinaoma was analyzed. Results The positive rate of maspin in the targeted hepatocellular carcinoma tissue (28.1% ) was significantly lower than that in the adjacent surrounding liver tissue (62.5 % ) as well as normal liver tissue (86.7 % ). The positive rate of maspin expression was related with tumor differentiation and metastasis (P 〈 0.05 ), but was not related with age, gender, the diameter of tumor, TMN stage and portal vein invasion(P 〉0.05 ). Conclusion Maspin shows a low expression in targeted hepatocellular carcinoma tissue, and its expression can be used as an index for the judgment of development and severity of bepatocellular carcinoma.
出处 《广西医学》 CAS 2012年第10期1285-1286,1290,共3页 Guangxi Medical Journal
基金 广西南宁市科学研究与技术开发计划项目(ZC2010004C)
关键词 原发性肝癌 MASPIN基因 免疫组织化学 Primary liver cancer Maspin gene Immunohistochemistry
  • 相关文献

参考文献10

二级参考文献33

  • 1Kyoko Kashima,Nobuyuki Ohike,Seishiro Mukai,Masashi Sato,Manabu Takahashi,Toshio Morohoshi.Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas[J].Hepatobiliary & Pancreatic Diseases International,2008,7(1):86-90. 被引量:9
  • 2张良明,耿冬梅,孙萍,姚卫东,王威.胃癌组织中maspin基因和HGF及E-cadherin的表达及相关性研究[J].肿瘤防治杂志,2005,12(20):1546-1549. 被引量:5
  • 3梁启廉,陈小东,王三明,李建文,黄冰,郑朝晖,陈雪松.VEGF和抑癌基因maspin在胃癌组织中的表达及意义[J].第三军医大学学报,2007,29(14):1416-1418. 被引量:18
  • 4Zou Z, Anisowicz A, Hendrix M J, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epthelial cells [ J]. Science, 1994, 263 (5146) :526 - 529.
  • 5Bailey CM, Khallkhali-Ellis Z, Seftor EA, et al. Biological functions of maspin [J]. J Cell Physiol,2006,209(3) :617 -624.
  • 6Zhang W, Zhang M. Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors [ J]. Int J Oncol,2002,20 ( 6 ) : 1145 - 1150.
  • 7Cho JH, Kim HS, Park CS, et al. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor [ J ]. Oral Oncol, 2007,43 ( 3 ) : 272 - 277.
  • 8Kumamoto H, Ooya K. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors [ J ]. J Oral Pathol Med,2007,36 (8) :488 - 494.
  • 9Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis [ J]. Arterioscler Thromb Vasc Biol, 2001, 21(10) : 1104 -1117.
  • 10Biliran H J, Sheng S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin [J]. Cancer Res, 2001, 61(24): 8676-8682.

共引文献4

同被引文献43

  • 1王孟春,杨艳敏,李晓晗,董芳,李岩.胃癌发生和演进中maspin和Kai1表达的临床病理意义[J].世界华人消化杂志,2004,12(10):2283-2286. 被引量:3
  • 2黄秋实,史成章,王红建,秦先锋.maspin及uPA在结肠癌组织中的表达及其临床意义[J].肿瘤基础与临床,2007,20(3):219-221. 被引量:7
  • 3于世风,高岩.口腔组织学与病理学[M].北京:北京大学医学出版社,2005.
  • 4Maass N, Teffner M, Rosel F, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast[J]. J Pathology, 2001,195 (3) :321-326.
  • 5Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells[J]. Science,1994,263(5146) :526-529.
  • 6Chen Z, Fan Z, McNeal JE, et al. Hepsin and maspin are in- versely expressed in laser capture microdissectioned prostate cancer[J]. Urol,2003,169(4):1316.
  • 7Friedrich MG, Toma MI, Petri S, et al. Expression of maspin in nonmuscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis[J]. Eur Urol, 2004,45 (6) 737-743.
  • 8Yasumatsu R, Nakashima N, Hirakawa, et al. Maspin ex- pression in stage I and lI oraltongue squamous cell carcinoma [J]. HeadNeck,2001,23(ll):962 966.
  • 9Takanami I, Abiko T, Koizumi S. Expression of maspin in non-small-cell lung cancer: correlation with clinical features [J]. Clin Lung Cancer,2008,9(6) :361.
  • 10Ozaki K, Hanazawa S. Porphyromonas gingivalis fimbriae in hibit caspase-3 mediated apoptosis of monocytic THP-1 cells under growth factor deprivation via Extracellular signal-regu iated kinase-dependent expression p21 Cip/WAFI[J]. Infect Immun,2001,69(ll) =4944-4950.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部